Provided by Tiger Fintech (Singapore) Pte. Ltd.

PROCEPT BioRobotics

54.16
+1.673.18%
Post-market: 54.15-0.0100-0.02%17:00 EDT
Volume:998.22K
Turnover:53.72M
Market Cap:2.97B
PE:-31.89
High:54.59
Open:52.85
Low:52.66
Close:52.49
Loading ...

PROCEPT BioRobotics Price Target Cut to $90.00/Share From $105.00 by Truist Securities

Dow Jones
·
26 Feb

Truist Securities Adjusts PROCEPT BioRobotics Price Target to $90 From $105, Maintains Buy Rating

MT Newswires Live
·
26 Feb

Strong Growth Potential for PROCEPT BioRobotics Amid Market Challenges

TIPRANKS
·
26 Feb

Positive Outlook for PROCEPT BioRobotics: Resilience and Growth Opportunities Justify Buy Rating

TIPRANKS
·
26 Feb

PROCEPT BioRobotics Corp (PRCT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

GuruFocus.com
·
26 Feb

Procept Biorobotics Corp : TD Cowen Cuts Target Price to $85 From $99

THOMSON REUTERS
·
26 Feb

PROCEPT BioRobotics Reports Strong 2024 Growth

TIPRANKS
·
26 Feb

Procept Biorobotics Corp : Leerink Partners Cuts Target Price to $91 From $102

THOMSON REUTERS
·
26 Feb

PROCEPT BioRobotics (PRCT) Receives a Hold from BTIG

TIPRANKS
·
26 Feb

Strong Growth and Strategic Expansion Drive Buy Rating for PROCEPT BioRobotics

TIPRANKS
·
26 Feb

PROCEPT BioRobotics (PRCT) Receives a Buy from William Blair

TIPRANKS
·
26 Feb

Stock Track | PROCEPT BioRobotics Soars 5.24% After-Hours on Better-Than-Expected Q4 2024 Results

Stock Track
·
26 Feb

PROCEPT BioRobotics Corporation (PRCT) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
26 Feb

Procept Biorobotics Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
26 Feb

PROCEPT BioRobotics Sees Q1 Revenue $65.5M Vs $66.1M Est

Benzinga
·
26 Feb

PROCEPT BioRobotics Q4 2024 GAAP EPS $(0.35) Misses $(0.33) Estimate, Sales $68.200M Beat $66.780M Estimate

Benzinga
·
26 Feb

BRIEF-Procept Biorobotics Q4 Net Income USD -18.856 Million Vs. IBES Estimate USD -17.3 Million

Reuters
·
26 Feb

Procept Biorobotics Q4 Gross Profit USD 43.672 Million

THOMSON REUTERS
·
26 Feb

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

GlobeNewswire
·
07 Feb

PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) institutional investors lost 12% over the past week but have profited from longer-term gains

Simply Wall St.
·
18 Jan